Hendaus Mohamed A, Jomha Fatima A
Department of Pediatrics, Sidra Medicine, Doha, Qatar.
Weill Cornell Medicine, Ar-Rayyan, Qatar.
J Biomol Struct Dyn. 2022;40(19):9568-9570. doi: 10.1080/07391102.2021.1927847. Epub 2021 May 17.
The number of people affected by COVID-19 is staggering and countries are rushing and competing to vaccinate their populations. However, there has been a concern about the association between COVID-19 vector-based vaccines and thrombosis. The proposed mechanism by which a COVID-19 vector-based vaccine can cause thrombosis is called vaccine-induced immune thrombotic thrombocytopenia (VITT). This commentary will provide an easy sketch of VITT as well as presentation of thrombosis after COVID-19 vaccines and proposed treatment.Communicated by Ramaswamy H. Sarma.
受新冠病毒影响的人数惊人，各国都在竞相为民众接种疫苗。然而，人们一直担心基于载体的新冠疫苗与血栓形成之间的关联。基于载体的新冠疫苗导致血栓形成的推测机制被称为疫苗诱导的免疫性血栓性血小板减少症（VITT）。本评论将简要概述VITT以及新冠疫苗接种后的血栓形成情况和建议的治疗方法。由拉马斯瓦米·H·萨尔马传达。
